Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 34 results for "ajanta pharma"

Vice President Ansari's visit will pave way for business oppor...

[Uganda], Feb. 22 (ANI): Honorary Consul Consulate of the republic of Uganda Madhusudan Agrawal on Wednesday hailed the visit of Vice President Hamid Ansari to the African nation, saying his visit would pave way for more business opportunities for the Indian ... Sify, 5 days ago

47 images for ajanta pharma

Money Control, 2 weeks ago
Financial Express, 1 month ago
india.com, 1 month ago
India.com, 1 month ago
India Infoline, 2 weeks ago
Sify, 1 month ago
The Freepress Journal, 1 month ago
Forbes India, 1 month ago
Livemint.com, 1 month ago
Sify, 1 month ago
India Infoline

Ajanta Pharma issues one procedural related 483, stock reacts

News Service | Mumbai | February 09, 2017 11:36 IST Ajanta Pharma has issued one procedural related 483 related to the company’s Paithan facility which was inspected by US FDA.
 India Infoline2 weeks ago Ajanta Pharma gets USFDA observation for Paithan facility  DNA2 weeks ago Ajanta Pharma: Updates on USFDA inspection of Paithan facility  Money Control2 weeks ago Ajanta Pharma slumps to over 6-1/2-month low over US FDA drug ban  Sify1 month ago
[x]  
Forbes India

No import alert on us: Ajanta Pharma

The company clarifies that some unrelated entity had imported one of its product sold in India and other emerging markets, with which Ajanta Pharma has no relation By Aveek Datta Forbes India Staff Published: Jan 24, 2017 Full Bio Image: Shutterstock ...
 Forbes India1 month ago Ajanta Pharma gets import ban for selling unapproved drug in US  Money Control1 month ago

Ajanta Pharma Q3 net up 25% at Rs 143 cr, denies import alert

Drug firm Ajanta Pharma todayreported a 25.15 per cent rise in its consolidated net profitto Rs 142.60 crore for the third quarter ended December 31,2016 mainly on account of robust sales.
 Money Control1 month ago Ajanta Pharma pares early losses post clarification on USFDA import alert  Business Standard1 month ago
Sify

Ajanta Pharma denies getting USFDA alert; Stock recovers after sharp fall

After a severe setback that resulted in a more than 14% fall in morning trades, Ajanta Pharma has recovered substantial ground this afternoon after the company said in a filing to the stock exchanges that there was no import alert by USFDA on the company's ...
 Sify1 month ago Ajanta Pharma denies alert from USFDA, says supply is on  DNA1 month ago Ajanta Pharma cracks on US FDA alerts  India Infoline1 month ago

Biocon, HDFC Bank, HCL Tech results on Tuesday

About 50 companies will announce their Q3 results on Tuesday. These include Ajanta Pharma, Aptech, Bharat Bijlee, Bharat Financial, Biocon, Crompton Greaves Consumer, EIH Associated, Greenply, HCL...
 Business Line1 month ago Ajanta Pharma to announce Q3 results  Business Standard1 month ago

Top buzzing midcap stocks to trade on January 24

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Ajanta Pharma, Karnataka Bank, GNFC, GSFC, MOIL and Ashoka Buildcon.
 Money Control1 month ago
Forbes India

Motilal Oswal's latest Wealth Creation Study tells investors to adopt 'focussed investing'

TCS was the biggest, and Ajanta Pharma the fastest, wealth creator in 2011-16 By Pravin Palande Forbes India Staff Published: Dec 12, 2016 Full Bio Image: Joshua Navalkar Motilal Oswal Financial Services unveiled its 21st Wealth Creation Study on Saturday.
 Forbes India2 months ago Motilal Oswal Financial unveils 21st annual wealth creation study  Business Line2 months ago How investors can fetch exceptional returns  Rediff.com2 months ago

Results to watch out for! Wockhardt, HDFC Bank, Ajanta Pharma in focus

The results which are expected today are Wockhardt, HDFC Bank, Bharti Airtel, Zee Ent, Biocon, TVS Motor, IDBI Bank,Bharat Financial Inclusion, Ajanta Pharma.
 India Infoline1 month ago

HC allows Indian firm to export drug in which Bayer has patent

In a setback to German pharma major 'Bayer', Delhi High Court has suspended its order restraining an Indian drug company from manufacturing and selling overseas an erectile dysfunction medicine, the patent for which was held by the foreign company. Justice R ...
 Business Standard4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less